Project Grant R21CA294049
Award Date 8/11/25
Completion Date 7/31/27
Dollars Obligated $395K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Virginia, USA
Similar Awards
- This federal Project Grant award of $164,484.00 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports the development and evaluation of smoking cessation messages targeted to adults who smoke nondaily. The project, conducted by the University of Kentucky Research Foundation, aims to create tailored communications that increase knowledge, worry, risk perceptions, motivation, and intentions to quit smoking among this population. The researchers will...
- This federal Project Grant award, funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research), is focused on developing a cue-based smoking cessation intervention delivered via telehealth for people who smoke lightly (PSLI). The $906,306 award, with a performance period from September 2025 to August 2028, aims to adapt and pilot test an intervention that combines cue-based treatment with standard cognitive behavioral therapy (CBT) to promote smoking cessation...
- This $129,480 Project Grant, awarded on December 1, 2024 by the National Cancer Institute (CFDA 93.398 Cancer Research Manpower), aims to examine tobacco use relapse among cancer survivors. The study will recruit 122 cancer survivors at high risk of relapse from the VCU Massey Cancer Center to complete surveys assessing intrapersonal factors (e.g., cancer worry, negative affect) and interpersonal factors (e.g., social support, social constraint) as predictors of tobacco use relapse. A subset...
- The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the University of Oklahoma Health Sciences Center to conduct a randomized factorial trial on smoking cessation interventions. The $625,201 award, effective January 1, 2025 through December 31, 2029, will evaluate the combined impact of varenicline medication plus nicotine lozenges, and a smartphone-based medication adherence intervention, on 7-day point prevalence...
- The University of Pittsburgh received a $2,202,321 Project Grant from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to conduct an experimental investigation on the impact of dyadic processes on smoking and cigarette craving. The 4-year project, running from August 2025 to July 2029, will examine how social factors, particularly romantic partner and friend dynamics, influence smoking behaviors and craving in an effort to develop a more comprehensive...
- The federal Project Grant award titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit" is funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) for $663,554.00 with an award date of August 18, 2025 and an ultimate completion date of July 31, 2030. The grant supports research to explore the use of harm reduction product sampling, such as e-cigarettes, heated tobacco products, and oral...
- The National Cancer Institute (NCI) awarded a $399,891 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Sensewhy, Inc. (UEI: N7FTT2U8NHX7) to evaluate the feasibility and clinical utility of the "Smokemon" wearable device for detecting smoking topography and predicting smoking lapses among cancer survivors who are daily smokers. The project will involve a one-week pre-quit observation period and a four-week post-quit observation period, during which...
- This federal Project Grant award of $619,175 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports a Type 1 hybrid effectiveness-implementation trial to evaluate a novel harm reduction approach for oncology outpatients who smoke but refuse traditional tobacco treatment. The study will directly compare rates of switching from cigarettes to e-cigarettes against standard care, while also assessing key barriers and facilitators to implementation. The...
- This Project Grant award of $226,504 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to understand tobacco use trajectories and related mechanisms among U.S. adults and youth representing minority and intersecting minority identities. The study aims to examine disparities in the use of diverse tobacco products, as well as the underlying mechanisms such as marketing exposure and product perceptions, within these populations. The research...
- This $515,632 Project Grant from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to prepare the U.S. and states for potential new cigarette product standards that could significantly increase smoking cessation rates. The research team at the University of Minnesota will provide state-specific estimates of the number of people who smoke (PWS) that will quit smoking in response to a menthol ban and nicotine reduction standard, as well as the...